Cutting edge: C3, a key component of complement activation, is not required for the development of myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis in mice (Q73365690)
Jump to navigation
Jump to search
scientific article published on 01 January 2001
Language | Label | Description | Also known as |
---|---|---|---|
English | Cutting edge: C3, a key component of complement activation, is not required for the development of myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis in mice |
scientific article published on 01 January 2001 |
Statements
Cutting edge: C3, a key component of complement activation, is not required for the development of myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis in mice (English)
D M Calida
C Constantinescu
E Purev
G X Zhang
E S Ventura
E Lavi
1 January 2001